Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Dills in a pickle

Article Abstract:

'Celebrity Super Powers' is a show where alleged celebrities are hypnotized to do silly things and is telecasted on Wednesday, June 30, at 7.30 pm on Nine Network Channel.

Author: Carlyon, Patrick
Publisher: A C P Computer Publications
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2004
Celebrity Super Powers (Television program)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Dumber and dumber

Article Abstract:

TELEVISION PROGRAMME REVIEW: Kath & Kim, ABC, Thursdays, 8.30pm

Author: Carlyon, Patrick
Publisher: A C P Computer Publications
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
Kath & Kim (Television program)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Badge of dishonour

Article Abstract:

TELEVISION PROGRAMME REVIEW: The Shield

Author: Carlyon, Patrick
Publisher: A C P Computer Publications
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
The Shield (Television program)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Television programs, Television Program Review
Similar abstracts:
  • Abstracts: Kin deep. Research and destroys . Green and gold blues
  • Abstracts: TD mulling U.S. Waterhouse sale. TD strikes Ameritrade deal
  • Abstracts: The last gasp. Big bang theory. Last stand in Warrnambool
  • Abstracts: Breaking the silence. Power trip
  • Abstracts: Licence to kill. Live at the wireless. The pulse superhuman
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.